Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease ; volume:9 ; number:1 ; day:16 ; month:3 ; year:2017 ; pages:1-14 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (16.3.2017), 1-14, 12.2017
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Lee, Spencer A. W.
- Contributor
-
Sposato, Luciano A.
Hachinski, Vladimir
Cipriano, Lauren E.
SpringerLink (Online service)
- DOI
-
10.1186/s13195-017-0243-0
- URN
-
urn:nbn:de:1111-201704062939
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Spencer A. W.
- Sposato, Luciano A.
- Hachinski, Vladimir
- Cipriano, Lauren E.
- SpringerLink (Online service)
Other Objects (12)
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Biomarkers in Alzheimer’s disease
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Biomarkers in Alzheimer’s disease
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Biomarkers in Alzheimer’s disease
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease